| PRLD |
Prelude Therapeutics Inc |
04 Feb 2025 |
1 |
$0 |
4 |
CLO, CFO, Corp Sec. |
05 Feb 2025, 16:34 |
| PRLD |
Prelude Therapeutics Inc |
19 Dec 2024 |
1 |
+$22,638 |
4 |
CLO, Interim CFO, Corp Sec. |
20 Dec 2024, 07:35 |
| PRLD |
Prelude Therapeutics Inc |
14 May 2024 |
1 |
$0 |
4 |
CLO, Interim CFO, Corp Sec. |
16 May 2024, 16:00 |
| PRLD |
Prelude Therapeutics Inc |
01 Mar 2024 |
1 |
$0 |
4 |
Chief Legal Officer, Corp Sec. |
04 Mar 2024, 18:07 |
| PRLD |
Prelude Therapeutics Inc |
24 May 2023 |
1 |
+$12,936 |
4 |
Chief Legal Officer, Corp Sec. |
25 May 2023, 16:07 |
| PRLD |
Prelude Therapeutics Inc |
01 Mar 2023 |
1 |
$0 |
4 |
Chief Legal Officer, Corp Sec. |
02 Mar 2023, 15:06 |
| PRLD |
Prelude Therapeutics Inc |
20 Feb 2023 |
0 |
$0 |
3 |
Chief Legal Counsel, Corp Sec. |
22 Feb 2023, 15:14 |
| /report/000141588923001855-lim-bryant-david-2023-01-20 |
Aceragen, Inc. |
20 Jan 2023 |
1 |
$0 |
4 |
SVP AND GENERAL COUNSEL |
02 Feb 2023, 19:08 |
| /report/000141588923000765-lim-bryant-david-2023-01-06 |
IDERA PHARMACEUTICALS, INC. |
06 Jan 2023 |
2 |
-$85,157 |
4 |
SVP AND GENERAL COUNSEL |
10 Jan 2023, 20:17 |
| /report/000141588922007545-lim-bryant-david-2022-07-06 |
IDERA PHARMACEUTICALS, INC. |
06 Jul 2022 |
1 |
$0 |
4 |
SVP AND GENERAL COUNSEL |
07 Jul 2022, 17:33 |
| /report/000141588922003752-lim-bryant-david-2022-04-01 |
IDERA PHARMACEUTICALS, INC. |
01 Apr 2022 |
1 |
$0 |
4 |
SVP AND GENERAL COUNSEL |
04 Apr 2022, 17:44 |
| /report/000141588922000793-lim-bryant-david-2022-01-24 |
IDERA PHARMACEUTICALS, INC. |
24 Jan 2022 |
1 |
$0 |
4 |
SVP AND GENERAL COUNSEL |
26 Jan 2022, 19:43 |
| /report/000141588921003585-lim-bryant-david-2021-07-08 |
IDERA PHARMACEUTICALS, INC. |
08 Jul 2021 |
1 |
$0 |
4 |
SVP AND GENERAL COUNSEL |
12 Jul 2021, 16:05 |